Penlac Nail Lacquer

This page contains recent news articles, when available, and an overview of Penlac Nail Lacquer but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Pharmaceutical Update  -  ‎Mar 13, 2009‎
Penlac Nail Lacquer Topical Solution 8% is now available from Dermik Laboratories Inc. for the treatment of toenail and fingernail fungus. ADVANCE for Physician Assistants

Perrigo gains from competitor's problems  -  Nov 1, 2007
On September 19, the Company announced it had received final approval from the FDA for ciclopirox topical solution, 8% (equivalent to Penlac Nail Lacquer), Globes,

Taro Receives FDA Approvals for Ciclopirox and Formulation of ...  -  Sep 24, 2007
The FDA determined the product to be safe and effective when compared with sanofi-aventis’ Penlac nail lacquer (ciclopirox) topical solution, 8 percent. FDA news (subscription),

FDA Approves Perrigo's Ciclopirox Topical Solution - Update [PRGO]  -  Sep 19, 2007
The Allegan, Michigan-based company said the product is the therapeutic equivalent to Sanofi Aventis US, LLC's Penlac Nail Lacquer, indicated for the RTT News,

Perrigo Gets FDA Approval For Ciclopirox Topical Solution - Quick ...  -  Sep 19, 2007
The product has been determined to be therapeutically equivalent to Sanofi Aventis US, LLC's Penlac Nail Lacquer, indicated for the treatment of mild to RTT News,

Tortured tootsies  -  Aug 2, 2007
Louisville Courier-Journal,But Beasley said he thinks patients sometimes have better success if they combine that therapy with a topical medication, such as Penlac Nail Lacquer

Ciclopirox 8% Nail Lacquer Topical Solution for the Treatment of ...  -  May 16, 2007
Journal of the American Podiatric Medical Association (subscription)Ciclopirox 8% nail lacquer (Penlac Nail Lacquer; Dermik Laboratories, Berwyn, Pennsylvania) is the first topical nail solution approved for use in the

The PMPRB to Hold a Public Hearing Into the Price of Penlac Nail ...  -  Mar 27, 2007
CCNMatthews (press release),Canada Inc. ("Sanofi-Aventis") and the price of the medicine Penlac Nail Lacquer ("Penlac"). A pre-hearing conference will also be held on June 6, 2007.

Update On Recent PMPRB Activities  -  Apr 18, 2007
Mondaq News Alerts (subcription),One Notice of Hearing issued on March 26 involves the drug Penlac Nail Lacquer which is sold in Canada by Sanofi-Aventis Canada Inc. Penlac is indicated as

:

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com/health lead to other sites. health.mongabay.com/health does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com/health responsible for dead or misdirected links.

IF YOU NEED A LINK/TEXT REMOVED FROM THIS PAGE, PLEASE CONTACT: mongabay (at) gmail.com